Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Science (New York, N.Y.)
|
July 15, 2006
Reexamining fusion power
Chauncey Starr, Robert L Hirsch, Herman Dieckamp, et al.
Seminars in Oncology
|
January 17, 2004
Ongoing prospective multicenter safety study of the cytoprotectant amifostine given subcutaneously: overview of trial design
Michael A Samuels, Isagani M Chico, Robert L Hirsch, et al.
Journal of Microbiological Methods
|
January 12, 2013
Agrobacterium tumefaciens-mediated transformation of the soybean pathogen Phomopsis longicolla
Shuxian Li, John B Ridenour, Hun Kim, et al.
Environmental Microbiology
|
November 19, 2013
UBL1 of Fusarium verticillioides links the N-end rule pathway to extracellular sensing and plant pathogenesis
John B Ridenour, Jonathon E Smith, Robert L Hirsch, et al.
Pediatric Pulmonology
|
May 15, 2003
Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry
Curt Parnes, Judith Guillermin, Rolf Habersang, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Science (New York, N.Y.)
|
July 15, 2006
Reexamining fusion power
Chauncey Starr, Robert L Hirsch, Herman Dieckamp, et al.
Seminars in Oncology
|
January 17, 2004
Ongoing prospective multicenter safety study of the cytoprotectant amifostine given subcutaneously: overview of trial design
Michael A Samuels, Isagani M Chico, Robert L Hirsch, et al.
Journal of Microbiological Methods
|
January 12, 2013
Agrobacterium tumefaciens-mediated transformation of the soybean pathogen Phomopsis longicolla
Shuxian Li, John B Ridenour, Hun Kim, et al.
Environmental Microbiology
|
November 19, 2013
UBL1 of Fusarium verticillioides links the N-end rule pathway to extracellular sensing and plant pathogenesis
John B Ridenour, Jonathon E Smith, Robert L Hirsch, et al.
Pediatric Pulmonology
|
May 15, 2003
Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry
Curt Parnes, Judith Guillermin, Rolf Habersang, et al.
Page
of 1